Home › Funds › Point72 Asset Management › OCUL
Point72 Asset Management position in OCUL
OCULAR THERAPEUTIX INC · Health Care
Latest position (Q2 2026)3.29M sh
Reported value held$32.33M
Portfolio Weight0.13%
First reportedQ2 2022
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2022 | 50.00K | $201.00K | New |
| Q3 2022 | 1.00K | $4.00K | Reduce |
| Q2 2024 | 2.71M | $18.51M | New |
| Q3 2024 | 2.04M | $17.75M | Reduce |
| Q4 2024 | 2.94M | $25.07M | Add |
| Q1 2025 | 1.94M | $14.24M | Reduce |
| Q1 2025 | 1.94M | $14.24M | Reduce |
| Q2 2025 | 1.90M | $17.67M | Reduce |
| Q2 2025 | 1.90M | $17.67M | Reduce |
| Q3 2025 | 4.60M | $53.79M | Add |
| Q4 2025 | 1.02M | $12.34M | Reduce |
| Q1 2026 | 5.53M | $46.88M | Add |
| Q2 2026 | 3.29M | $32.33M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding OCUL
- Fidelity Management & Research (FMR) 32.84M sh · $322.53M · Q2 2026
- BlackRock Inc 19.38M sh · $190.28M · Q2 2026
- Vanguard Group 11.58M sh · $140.52M · Q4 2025
- Geode Capital Management 5.02M sh · $49.32M · Q2 2026
- Balyasny Asset Management 3.25M sh · $31.87M · Q2 2026
- Northern Trust Corp 1.80M sh · $17.67M · Q2 2026
- Goldman Sachs Group 1.76M sh · $17.30M · Q2 2026
- UBS Group AG 1.55M sh · $15.23M · Q2 2026
- Charles Schwab Investment Management 1.53M sh · $15.06M · Q2 2026
- Invesco Ltd 1.34M sh · $13.20M · Q2 2026
- Two Sigma Investments 1.22M sh · $11.97M · Q2 2026